Transient immunosuppression stops rejection of virus-transduced enhanced green fluorescent protein in rabbit retina

被引:9
作者
Doi, K
Kong, J
Hargitai, J
Goff, SP
Gouras, P
机构
[1] Columbia Univ Coll Phys & Surg, Dept Ophthalmol, New York, NY 10032 USA
[2] Columbia Univ Coll Phys & Surg, Dept Biochem & Mol Biol, New York, NY 10032 USA
[3] Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA
关键词
D O I
10.1128/JVI.78.20.11327-11333.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The expression of lentivirus-transduced enhanced green fluorescent protein (EGFP) was detectable in rabbit retinal pigment epithelium (RPE) within 3 to 5 days after subretinal injection of the vector. Within 2 to 3 weeks, EGFP-expressing cells were eliminated by rejection. In the current experiments, we monitor serum antibody titers for EGFP before and after transduction and determine whether systemic immunosuppression prevents recognition of EGFP by the immune system. While all control rabbits developed antibodies against EFGP and showed signs of rejection, no such evidence was observed with animals which received immunosuppression. One month of systemic immunosuppression permanently prevented rejection of RPE with EGFP expression. Fluorescence has been maintained for more than a year. If a control eye was injected with the same virus after terminating immunosuppression, both eyes showed signs of rejection. The lack of rejection is not due to tolerance but to a failure of the animals to detect the foreign protein. Detection must depend upon a brief window of time after surgery needed to introduce the vector, perhaps related to a concurrent but transient inflammation. This strategy may be useful in managing other types of rejection in the retina.
引用
收藏
页码:11327 / 11333
页数:7
相关论文
共 23 条
  • [1] Long-term outcome of RPE allografts in non-immunosuppressed patients with AMD
    Algvere, PV
    Gouras, P
    Kopp, ED
    [J]. EUROPEAN JOURNAL OF OPHTHALMOLOGY, 1999, 9 (03) : 217 - 230
  • [2] *ASS RES VIS OPHTH, 2002, ARVO RES US AN RES
  • [3] Exchange of surface proteins impacts on viral vector cellular specificity and transduction characteristics: the retina as a model
    Auricchio, A
    Kobinger, G
    Anand, V
    Hildinger, M
    O'Connor, E
    Maguire, AM
    Wilson, JM
    Bennett, J
    [J]. HUMAN MOLECULAR GENETICS, 2001, 10 (26) : 3075 - 3081
  • [4] Stable transgene expression in rod photoreceptors after recombinant adeno-associated virus-mediated gene transfer to monkey retina
    Bennett, J
    Maguire, AM
    Cideciyan, AV
    Schnell, M
    Glover, E
    Anand, V
    Aleman, TS
    Chirmule, N
    Gupta, AR
    Huang, YJ
    Gao, GP
    Nyberg, WC
    Tazelaar, J
    Hughes, J
    Wilson, JM
    Jacobson, SG
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (17) : 9920 - 9925
  • [5] HIGH-EFFICIENCY TRANSFORMATION OF MAMMALIAN-CELLS BY PLASMID DNA
    CHEN, C
    OKAYAMA, H
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1987, 7 (08) : 2745 - 2752
  • [6] COLE GA, 1972, NATURE, V238, P335, DOI 10.1038/238335a0
  • [7] Feline immunodeficiency virus vectors. Gene transfer to mouse retina following intravitreal injection
    Derksen, TA
    Sauter, SL
    Davidson, BL
    [J]. JOURNAL OF GENE MEDICINE, 2002, 4 (05) : 463 - 469
  • [8] Lentiviral transduction of green fluorescent protein in retinal epithelium: evidence of rejection
    Doi, K
    Hargitai, J
    Kong, J
    Tsang, SH
    Wheatley, M
    Chang, S
    Goff, S
    Gouras, P
    [J]. VISION RESEARCH, 2002, 42 (04) : 551 - 558
  • [9] Stable and efficient gene transfer into the mutant retinal pigment epithelial cells of the Mitfvit mouse using a lentiviral vector
    Galileo, DS
    Hunter, K
    Smith, SB
    [J]. CURRENT EYE RESEARCH, 1999, 18 (02) : 135 - 142
  • [10] Immunogenicity of enhanced green fluorescent protein (EGFP) in BALB/c mice:: identification of an H2-Kd-restricted CTL epitope
    Gambotto, A
    Dworacki, G
    Cicinnati, V
    Kenniston, T
    Steitz, J
    Tüting, T
    Robbins, PD
    DeLeo, AB
    [J]. GENE THERAPY, 2000, 7 (23) : 2036 - 2040